DeutschNewstral
Article
The Times of India on 2022-01-27 21:31
Covaxin, Covishield get regular market nod, with some riders
Related news
- Covishield, Covaxin granted conditional market nodThe Times of India
CDSCO expert panel recommends nod to study on mixing doses of Covaxin, CovishieldThe Hindu- Regular market approval granted for Covishield, Covaxin for use in adult populationThe Hindu
- 'Covishield, Covaxin can protect against Omicron'The Times of India
- DCGI approves study on mixing Covaxin, CovishieldThe Times of India
- Study on Covaxin, Covishield mix shows better results, ICMR saysThe Times of India
- Covishield, Covaxin to get full approval but won’t be retailingThe Times of India
- Covishield-Covaxin mix offers better shield, says ICMR studyThe Times of India
- Live: Corbevax gets nod as booster after Covishield, CovaxinThe Times of India
- Won't recognise your vaccine certificates if you don't clear Covaxin, Covishield: India to EUThe Times of India
- Mix and match of Covishield and Covaxin safe, more effective: ICMR studyThe Times of India
- Corbevax, Covaxin get drug regulator nod for use in childrenThe Hindu
- Canada yet to recognise Covaxin even after WHO nodThe Times of India
- Covid: Vaccination for kids only after nod to CovaxinThe Times of India
- Reports misleading, Covaxin nod not a rush job: GovtThe Times of India
- MNCs tried to scuttle WHO nod for Covaxin: CJI RamanaThe Times of India
- Corbevax gets nod as booster after two doses of Covishield or CovaxinThe Hindu
- Covishield for teens on CoWin sparks some confusionThe Times of India
- Covid-19: PM Modi pushed for Covaxin nod at G20 meet with WHO chiefThe Times of India
- Better protection with Covishield-Covaxin combination: ICMRThe Hindu